How big is Rxsim's plan?

Rxsim's plan reported $110K in assets and 249 participants for 2024.

Original filing (PDF)20250721094956NAL0001661904001

Rxsim

Name: Rxsim — Med X Pharmacy 401(k) Plan, Form 5500 (2024)
Creator: Rxsim
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Med X Pharmacy 401(k) Plan

401(k) retirement plan · Rxsim's Med X Pharmacy 401(k) Plan held $110K in plan assets for 249 participants in 2024.

Signals · 1

No auditor on file

Active participants

249

Accounts w/ balance

Plan assets (EOY)

$110K

Net assets (EOY)

$110K

People on this filing

Marcus Bowie signed Rxsim's 2024 Form 5500 as plan administrator.

Marcus Bowie — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Rxsim's EIN is 83-3548481.

EIN 83-3548481

Plan number 001

Plan year 2024

ACK ID 20250721094956NAL0001661904001

Official Form 5500 document

Download the official 2024 Form 5500 (PDF) for Rxsim from the U.S. Department of Labor's EFAST2 system.

Download the official 2024 Form 5500 (PDF)

Plan features

Rxsim's plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for RXSIM.

Finding similar companies…

Plan health score

Average plan with room to improve

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

Total plan cost

n/a

Plan health

Vendor & structure

100

Knocking points off

No independent qualified public accountant (IQPA) named.
Low account-holder ratio — balance-holders per active participant in the bottom quartile of peers (3rd percentile).

Helping the score